NVG:NYE-Nuveen AMT Free Municipal Credit Income (USD)

FUND | Medical Distribution |

Last Closing

USD 12.42

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.31M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

+0.84 (+0.33%)

USD 46.78B
CAH Cardinal Health Inc

+0.03 (+0.02%)

USD 30.74B
MCK McKesson Corporation

+0.23 (+0.04%)

N/A
OMI Owens & Minor Inc

-0.06 (-0.40%)

N/A

ETFs Containing NVG

MFLX First Trust Flexible Muni.. 0.84 % 0.00 %

-0.06 (-0.32%)

USD 0.01B
PGAL 0.00 % 0.57 %

N/A

N/A
MCEF 0.00 % 0.75 %

N/A

N/A
XMPT VanEck CEF Municipal Inco.. 0.00 % 0.40 %

-0.05 (-0.32%)

N/A
CD47:XETRA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.31% 20% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.31% 20% F 43% F
Trailing 12 Months  
Capital Gain 4.37% 40% F 47% F
Dividend Return 5.87% 100% F 75% C
Total Return 10.24% 40% F 50% F
Trailing 5 Years  
Capital Gain -26.81% 20% F 20% F
Dividend Return 21.80% 100% F 68% D+
Total Return -5.01% 20% F 22% F
Average Annual (5 Year Horizon)  
Capital Gain -4.10% 33% F 15% F
Dividend Return -1.20% 33% F 16% F
Total Return 2.90% 80% B- 62% D
Risk Return Profile  
Volatility (Standard Deviation) 22.00% 67% D+ 50% F
Risk Adjusted Return -5.44% 33% F 17% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.